High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases

Analytical Cellular Pathology

Volumn 33, Issue 5-6, 2010, Pages 245-255

  Steinbakk, Anita ^a,b   Malpica, Anais ^c   Slewa, Aida ^a   Gudlaugsson, Einar ^a,b   Janssen, Emiel A M ^a   Arends, Mark ^d   Kruse, Arnold Jan ^e   Yinhua, Yu ^c   Feng, Weiwei ^f   Baak, Jan P ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f FUDAN UNIVERSITY   (China)

Author keywords

Endometrial cancer; endometrioid; FIGO stage 1; MSI; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SURVIVAL RATE; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY;

TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; FEMALE; HUMANS; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79955652224     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.3233/ACP-CLO-2010-0550     Document Type: Article

References (44)

1. H.J. An, K.I. Kim, J.Y. Kim et al., Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators, Am. J. Surg. Pathol. 31 (2007), 846-853. (Pubitemid 47165137)
2. M. Arafa, F. Kridelka, V. Mathias et al., High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma, Histopathology 53 (2008), 525-532.
3. J.P. Baak, W. Snijders, B. Van Diermen, P.J. Van Diest, F.W. Diepenhorst and J. Benraadt, Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in International Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma, J. Clin. Oncol. 21 (2003), 4214-4221. (Pubitemid 46606191)
4. P. Baldinu, A. Cossu, A. Manca et al., Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma, Cancer 94 (2002), 3157-3168. (Pubitemid 34670499)
5. J.B. Basil, P.J. Goodfellow, J.S. Rader, D.G. Mutch and T.J. Herzog, Clinical significance of microsatellite instability in endometrial carcinoma, Cancer 89 (2000), 1758-1764.
6. C. Bilbao, P.C. Lara, R. Ramirez et al., Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer, Int. J. Radiat. Oncol. Biol. Phys. 76 (2010), 9-13.
7. D. Black, R.A. Soslow, D.A. Levine et al., Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma, J. Clin. Oncol. 24 (2006), 1745-1753. (Pubitemid 46622146)
8. O. Buhard, F. Cattaneo, Y.F. Wong et al., Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors, J. Clin. Oncol. 24 (2006), 241-251. (Pubitemid 46622053)
9. O. Buhard, N. Suraweera and A. Lectard, Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis, Dis. Markers 20 (2004), 251-257. (Pubitemid 40164097)
10. R.F. Caduff, C.M. Johnston, S.M. Svoboda-Newman, E.L. Poy, S.D. Merajver and T.S.I. Frank, Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma, Am. J. Pathol. 148 (1996), 1671-1678. (Pubitemid 26135906)
11. J.M. Cunningham, E.R. Christensen, D.J. Tester et al., Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability, Cancer Res. 58 (1998), 3455-3460. (Pubitemid 28371090)
12. S. Fiumicino, A. Ercoli, G. Ferrandina et al., Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma, J. Clin. Oncol. 19 (2001), 1008-1014. (Pubitemid 32176275)
13. D. Furlan, I. Carnevali, B. Marcomini et al., The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas, Clin. Cancer Res. 12 (2006), 3329-3336.
14. C. Gurin, M. Federici, L. Kang and J. Boyd, Causes and consequences of microsatellite instability in endometrial carcinoma, Cancer Res. 59 (1999), 462-466. (Pubitemid 29048884)
15. J.L. Hecht and G. Mutter, Molecular and pathologic aspects of endometrial carcinogenesis, J. Clin. Oncol. 24 (2006), 4783-4791. (Pubitemid 46630943)
16. A. Hirasawa, D. Aoki, J. Inoue et al., Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancer, Clin. Cancer Res. 9 (2003), 5675-5682. (Pubitemid 37499490)
17. L.H. Honoré, J. Hanson and S.E. Andrew, Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables, Int. J. Gynecol. Cancer 16 (2006), 1386-1392. (Pubitemid 43886774)
18. N. Horowitz, K. Pinto, D.G. Mutch et al., Microsatellite instability, MLH1 promoter methylation and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia, Gynecol. Oncol. 86 (2002), 62-68. (Pubitemid 34757053)
19. W. Ju, H.M. Park, S.N. Lee, S.H. Sung and S.C. Kim, Loss of hMLH1 expression is associated with less aggressive clinicopathological features in sporadic endometrioid endometrial adenocarcinoma, J. Obstet. Gynaecol. Res. 32 (2006), 454-460. (Pubitemid 44410975)
20. S. Kang, J.M. Lee, E.S. Jeon et al., RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma, Int. J. Cancer 119 (2006), 1316-1321. (Pubitemid 44258806)
21. M. Kawaguchi, M. Yanokura, K. Bonno et al., Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer, Int. J. Oncol. 34 (2009), 1541-1547.
22. H. Korner, K. Soreide, P.J. Stokkeland and J.A. Söreide, Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis, Ann. Surg. Oncol. 14 (2007), 417-423. (Pubitemid 46175284)
23. R.J. Kurman, R.J. Zaino and H.J. Norris, Endometrial carcinoma: Clinical and pathological features, in: Baustein's Pathology of the Female Genital Tract, 4th edn, R.J. Kurman, ed., Springer, New York, 1994, pp. 448-449.
24. H. Lagarda, L. Catasus, R. Arguelles, X. Matias-Guiu and J. Prat, K-ras mutations in endometrial carcinomas with microsatellite instability, J. Pathol. 193 (2001), 193-199. (Pubitemid 32118131)
25. N.D. MacDonald, H.B. Salvesen, A. Ryan, O.E. Iversen, L.A. Akslen and I.J. Jacobs, Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas, Cancer Res. 60 (2000), 1750-1752. (Pubitemid 30183451)
26. G.L. Maxwell, J.I. Risinger, A.A. Alvarez, J.C. Barrett and A. Berchuck, Favorable survival associated with microsatellite instability in endometrioid endometrial cancers, Obstet. Gynecol. 97 (2001), 417-422. (Pubitemid 32184704)
27. G. Moreno-Bueno, D. Hardission, C. Sanchez et al., Abnormalities of the APC/bata-catenin pathway in endometrial cancer, Oncogene 21 (2002), 7981-7990. (Pubitemid 35430609)
28. R. Muresu, M.C. Sini, A. Cossu et al., Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer, Eur. J. Cancer 38 (2002), 1802-1809.
29. A. Ørbo, K. Eklo and M. Kopp, A semiautomated test for microsatellite instability and its significance for the prognosis of sporadic endometrial cancer in northern Norway, Int. J. Gynecol. Pathol. 21 (2002), 27-33. (Pubitemid 34008350)
30. J. Pallares, A. Velasco, N. Eritja et al., Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrioid carcinoma, Mod. Pathol. 21 (2008), 691-699. (Pubitemid 351744834)
31. S. Pecorelli, Revised FIGO staging for carcinoma of the vulva, cervix and endometrium, Int. J. Gynaecol. Obstet. 105 (2009), 103-104.
32. G. Peiró, J. Diebold, P. Lohse, G.B. Baretton and U. Löhrs, Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma, Hum. Pathol. 3 (2002), 347-354.
33. J.M. Pijnenborg, G.C. Dam-de Veen, J. De Haan,M. Van Engeland and P.G. Groothuis, Defective mismatch repair and the development of recurrent endometrial carcinoma, Gynecol. Oncol. 94 (2004), 550-559. (Pubitemid 39024566)
34. S. Popat, R. Hubner and R.S. Houlston, Systematic review of microsatellite instability and colorectal cancer prognosis, J. Clin. Oncol. 23 (2005), 609-618. (Pubitemid 46224239)
35. G. Poulogiannis, I. Frayling and M.J. Arends, DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome, Histopathology, to appear.
36. K. Søreide, E.A. Janssen, H. Søiland, H. Körner and J.P. Baak, Microsatellite instability in colorectal cancer, Br. J. Surg. 93 (2006), 395-406.
37. K. Søreide, A. Slewa, P.J. Stokkeland et al., Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection, Cancer 115 (2009), 271-282.
38. A. Steinbakk, I. Skaland, E. Gudlaugsson et al., The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer, Am. J. Obstet. Gynecol. 200 (2009), 78.e1-78.e8.
39. Y. Suehiro, T. Okada, K. Anno et al., Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation, Clin. Cancer Res. 14 (2008), 3354-3361.
40. N. Suraweera, A. Duval, M. Reperant et al., Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR, Gastroenterology 123 (2002), 1804-1811. (Pubitemid 35408304)
41. H.W. Van der Putten, J.P. Baak, T.J. Koenders, P.H. Kurver, H.G. Stolk and L.A. Stolte, Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma, Cancer 63 (1998), 1378-1387.
42. Y.F. Wong, T.K. Cheung, K.W. Lo et al., Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel ofmarkers, Carcinogenesis 27 (2006), 951-955.
43. R.J. Zaino, S.G. Silverberg, H.J. Norris, B.N. Bundy, C.P.Morrow and T. Okagaki, The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma, A Gynecologic Oncology Group study, Int. J. Gynecol. Pathol. 13 (1994), 29-36. (Pubitemid 24006331)
44. I. Zighelboim, P.J. Goodfellow, F. Gao et al., Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type, J. Clin. Oncol. 25 (2007), 2042-2048. (Pubitemid 46972789)